Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
Conditions
- Extensive-stage Small Cell Lung Cancer (ES-SCLC)
- Extensive Stage Lung Small Cell Cancer
- Extensive-Stage Small-Cell Lung Cancer
- Extensive Disease Small Cell Lung Cancer
Interventions
- DRUG: Tafolecimab
- DRUG: Sintilimab (approved)
- DRUG: Etoposide
- DRUG: Carboplatin / Cisplatin
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators